Seoul: Stocks edge lower, biopharma shares top drag

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

[SEOUL] South Korea's Kospi stock index slipped on Monday, dragged by leading biopharma shares. The Korean won weakened against the dollar and bond yields fell. The Kospi closed 5.65 points, or 0.27 per cent, weaker at 2,080.44. Read more at The Business Times.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 15. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Seoul: Stocks tick up ahead of key events; won inches up[SEOUL] South Korea's Kospi stock index saw modest gains on Wednesday as investors took a cautious stance ahead of key events. The South Korean won inched up while bond yields rose. Read more at The Business Times.
Fonte: BusinessTimes - 🏆 15. / 51 Consulte Mais informação »

Seoul: Stocks dip as trade uncertainties remain, won hits 5-1/2 month high[SEOUL] South Korea's Kospi stock index sagged on Tuesday amid uncertainty over whether China and the U.S. will be able to resolve their trade differences. The won jumped, hitting its highest since June, tracking the Chinese yuan. South Korean bond yields fell. Read more at The Business Times.
Fonte: BusinessTimes - 🏆 15. / 51 Consulte Mais informação »

Centurion JV completes acquisition of Benikea Hotel in SeoulMAINBOARD-LISTED Centurion Corporation on Wednesday morning said it has completed the acquisition of South Korea's Benikea Hotel for S$16.6 million. The company has said that the hotel will be refurbished as student accommodation. Read more at The Business Times.
Fonte: BusinessTimes - 🏆 15. / 51 Consulte Mais informação »